These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14098708)

  • 1. [STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. II. ON VARIOUS DISEASES EXCEPT ARTERIOSCLEROSIS].
    MATSUDA T
    Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():590-7. PubMed ID: 14098708
    [No Abstract]   [Full Text] [Related]  

  • 2. [STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. I. ON NORMAL AND ARTERIOSCLEROTIC CASES].
    MATSUDA T
    Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():581-9. PubMed ID: 14095688
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE ORIGIN OF ATONIC HEMORRHAGE AND AFIBRINOGENEMIA, AND ANTIPLASMIN AND ANTITRYPSIN BLOOD DISEASES].
    MAKI M
    Nihon Sanka Fujinka Gakkai Zasshi; 1963 Nov; 15():1207-10. PubMed ID: 14096727
    [No Abstract]   [Full Text] [Related]  

  • 4. [RELATION OF ANTIPLASMIN AND ANTITRYPSIN IN THE BLOOD PLASMA].
    MAKI M
    Nihon Sanka Fujinka Gakkai Zasshi; 1963 Oct; 15():1143-6. PubMed ID: 14092838
    [No Abstract]   [Full Text] [Related]  

  • 5. ENHANCEMENT OF FIBRINOLYSIS AND ANTAGONISM OF ANTIPLASMIN BY REVERSIBLE PLASMIN INHIBITORS.
    MAXWELL RE; LEWANDOWSKI V; NICKEL VS
    Life Sci (1962); 1965 Jan; 4():45-51. PubMed ID: 14257064
    [No Abstract]   [Full Text] [Related]  

  • 6. [ANTIPLASMIN ACTIVITY OF THE PANCREATIC TRYPSIN INHIBITOR AND OF EPSILON-AMINOCAPROIC ACID].
    DEBARBIERI A; SCEVOLA ME; FRANCHINI M
    Boll Chim Farm; 1964 Jan; 103():37-40. PubMed ID: 14131376
    [No Abstract]   [Full Text] [Related]  

  • 7. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR.
    NANNINGA LB; GUEST MM
    Arch Biochem Biophys; 1964 Dec; 108():542-51. PubMed ID: 14244698
    [No Abstract]   [Full Text] [Related]  

  • 8. CORRELATION OF ANTIPLASMIN TO ANTITRYPSIN AND ANTICHYMOTRYPSIN IN HUMAN PLASMA.
    MAKI M; KIKUCHI T
    Tohoku J Exp Med; 1963 Nov; 81():188-97. PubMed ID: 14083618
    [No Abstract]   [Full Text] [Related]  

  • 9. [SEMEIOLOGICAL AND CLINICAL SIGNIFICANCE OF BASOPHIL GRANULOCYTES IN NORMAL AND PATHOLOGICAL CONDITONS].
    FERLAZZO B; LAROSA G; OLIVERI D; STAITI A
    Omnia Med Ther; 1963; 41():497-523. PubMed ID: 14159129
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON THE DEFENSIVE REFLEX ANTIPLASMIN SYSTEM IN THE BODY].
    KUDRIASHOV BA; KALISHEVSKAIA TM
    Biull Eksp Biol Med; 1963 Sep; 56():29-33. PubMed ID: 14124776
    [No Abstract]   [Full Text] [Related]  

  • 11. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY].
    MORIAU M; DE VRIES SI; DIK HJ
    Thromb Diath Haemorrh; 1964 Jan; 10():355-78. PubMed ID: 14113376
    [No Abstract]   [Full Text] [Related]  

  • 12. [STUDY OF THE ANTIFIBRINOLYTIC PROPERTIES OF KUNITZ'S PANCREATIC INHIBITOR. (TESTS IN VITRO AND IN VIVO)].
    GIBELLI A; SCARDI F
    Gazz Int Med Chir; 1963 Oct; 67():2105-16. PubMed ID: 14095279
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
    Zhabin SG; Zorin NA; Musatov MI
    Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.
    AMBRUS CM; MARKUS G
    Am J Physiol; 1960 Sep; 199():491-4. PubMed ID: 13682944
    [No Abstract]   [Full Text] [Related]  

  • 15. [CONSIDERATIONS ON THE SO-CALLED PARANEOPLASTIC SYNDROMES].
    BOARI L; MADINI GC
    Boll Soc Med Chir Cremona; 1963; 17():19-39. PubMed ID: 14112951
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the changes of plasmin activity caused by radiation treatment in cancer patients and effects of antiplasmin (Ipsilon) administration].
    YAMASHITA H; IGARI S; TANAKA T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1961 Sep; 21():646-55. PubMed ID: 14008906
    [No Abstract]   [Full Text] [Related]  

  • 17. [ANTIPLASMIN DRUGS].
    MATSUOKA S; OGUCHI G
    Sogo Rinsho; 1963 Oct; 12():1986-91. PubMed ID: 14092546
    [No Abstract]   [Full Text] [Related]  

  • 18. [NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM].
    KUDRIASHOV BA; ANDREENKO GV; KALISHEVSKAIA TM
    Probl Gematol Pereliv Krovi; 1964 Apr; 9():12-5. PubMed ID: 14195816
    [No Abstract]   [Full Text] [Related]  

  • 19. INACTIVATION OF ANTIPLASMIN AND COMPLEMENT C1 IN HUMAN PLASMA RENDERED FIBRINOLYTIC BY SYNTHETIC ORGANIC COMPOUNDS.
    VONKAULLA KN
    Thromb Diath Haemorrh; 1963 Nov; 10():151-63. PubMed ID: 14081277
    [No Abstract]   [Full Text] [Related]  

  • 20. [On plasmin and antiplasmin titration].
    KOTSCHY M
    Postepy Hig Med Dosw; 1961; 15():607-15. PubMed ID: 14458817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.